432 related articles for article (PubMed ID: 34891172)
1. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
Zhao BW; Hu L; You ZH; Wang L; Su XR
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
[TBL] [Abstract][Full Text] [Related]
2. Drug-disease association prediction using semantic graph and function similarity representation learning over heterogeneous information networks.
Zhao BW; Su XR; Yang Y; Li DX; Li GD; Hu PW; Zhao YG; Hu L
Methods; 2023 Dec; 220():106-114. PubMed ID: 37972913
[TBL] [Abstract][Full Text] [Related]
3. Hierarchical Negative Sampling Based Graph Contrastive Learning Approach for Drug-Disease Association Prediction.
Wang Y; Song J; Dai Q; Duan X
IEEE J Biomed Health Inform; 2024 May; 28(5):3146-3157. PubMed ID: 38294927
[TBL] [Abstract][Full Text] [Related]
4. A geometric deep learning framework for drug repositioning over heterogeneous information networks.
Zhao BW; Su XR; Hu PW; Ma YP; Zhou X; Hu L
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36125202
[TBL] [Abstract][Full Text] [Related]
5. RLFDDA: a meta-path based graph representation learning model for drug-disease association prediction.
Zhang ML; Zhao BW; Su XR; He YZ; Yang Y; Hu L
BMC Bioinformatics; 2022 Dec; 23(1):516. PubMed ID: 36456957
[TBL] [Abstract][Full Text] [Related]
6. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
Jarada TN; Rokne JG; Alhajj R
BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
[TBL] [Abstract][Full Text] [Related]
7. NEDD: a network embedding based method for predicting drug-disease associations.
Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M
BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396
[TBL] [Abstract][Full Text] [Related]
8. Link Prediction Only With Interaction Data and its Application on Drug Repositioning.
Liu J; Zuo Z; Wu G
IEEE Trans Nanobioscience; 2020 Jul; 19(3):547-555. PubMed ID: 32340956
[TBL] [Abstract][Full Text] [Related]
9. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.
Luo Y; Zhao X; Zhou J; Yang J; Zhang Y; Kuang W; Peng J; Chen L; Zeng J
Nat Commun; 2017 Sep; 8(1):573. PubMed ID: 28924171
[TBL] [Abstract][Full Text] [Related]
10. Exploring potential circRNA biomarkers for cancers based on double-line heterogeneous graph representation learning.
Zhang Y; Wang Z; Wei H; Chen M
BMC Med Inform Decis Mak; 2024 Jun; 24(1):159. PubMed ID: 38844961
[TBL] [Abstract][Full Text] [Related]
11. DTiGNN: Learning drug-target embedding from a heterogeneous biological network based on a two-level attention-based graph neural network.
Muniyappan S; Rayan AXA; Varrieth GT
Math Biosci Eng; 2023 Mar; 20(5):9530-9571. PubMed ID: 37161255
[TBL] [Abstract][Full Text] [Related]
12. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
[TBL] [Abstract][Full Text] [Related]
13. Prediction of drug-disease associations by integrating common topologies of heterogeneous networks and specific topologies of subnets.
Gao L; Cui H; Zhang T; Sheng N; Xuan P
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34850815
[TBL] [Abstract][Full Text] [Related]
14. Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network.
Sun X; Wang B; Zhang J; Li M
IEEE J Biomed Health Inform; 2022 Nov; 26(11):5757-5765. PubMed ID: 35921345
[TBL] [Abstract][Full Text] [Related]
15. Computational drug repositioning using meta-path-based semantic network analysis.
Tian Z; Teng Z; Cheng S; Guo M
BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
[TBL] [Abstract][Full Text] [Related]
16. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H; Song Y; Guan J; Luo L; Zhuang Z
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
[TBL] [Abstract][Full Text] [Related]
17. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
[TBL] [Abstract][Full Text] [Related]
18. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning by integrating target information through a heterogeneous network model.
Wang W; Yang S; Zhang X; Li J
Bioinformatics; 2014 Oct; 30(20):2923-30. PubMed ID: 24974205
[TBL] [Abstract][Full Text] [Related]
20. DLDTI: a learning-based framework for drug-target interaction identification using neural networks and network representation.
Zhao Y; Zheng K; Guan B; Guo M; Song L; Gao J; Qu H; Wang Y; Shi D; Zhang Y
J Transl Med; 2020 Nov; 18(1):434. PubMed ID: 33187537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
